Mitha E, Ferguson M, Wilhase AC, De Looze F, et al. Immunogenicity and Safety of the AS01E-adjuvanted Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine in Adults Aged 18-49 Years at Increased Risk of RSV Disease Compared with Adults Aged >/=60 Years. Clin Infect Dis 2026 Feb 27:ciag058. doi: 10.1093.
PMID: 41757519